LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Ready-to-Use Control Determines Linearity for Special Diabetes Tests

By LabMedica International staff writers
Posted on 13 Apr 2015
Print article
The new, ready-to-use “Linearity LQ Special Diabetes,” an assayed quality-control material consisting of 5 distinct levels that demonstrate a linear relationship to each other when assayed for C-peptide, fructosamine, and insulin
The new, ready-to-use “Linearity LQ Special Diabetes,” an assayed quality-control material consisting of 5 distinct levels that demonstrate a linear relationship to each other when assayed for C-peptide, fructosamine, and insulin (Photo courtesy of AUDIT MICROCONTROLS)
A new addition to clinical lab quality control products simulates human patient serum samples for the purpose of determining linearity, calibration verification, and verification of reportable range for special diabetes tests.

The Linearity LQ Special Diabetes from AUDIT MicroControls, Inc. (Eatonton, GA, USA) is an assayed quality-control material consisting of 5 distinct levels that demonstrate a linear relationship to each other when assayed for C-peptide, fructosamine, and insulin. It is a ready-to-use liquid product with open vial stability of 7 days when stored at 2–8 °C.

AUDIT MicroControls provides “Auditor QC,” a free on-line, real-time data reduction program that offers Levey-Jennings charts and peer group analysis for daily quality control product users, as well as linearity graphs and peer group analysis. Report results are given immediately in an inspector friendly format and stored on the Auditor QC website for convenient future reference.

AUDIT is a total solution in daily quality controls and calibration verification materials, providing high-quality products, easy-to-use data management tools, and personalized service. Synergistic partnership with leading manufacturer and supplier Aalto Scientific enables AUDIT to offer significant cost savings and a broad line of superior solutions that address challenges faced by today’s clinical labs.

Related Links:

AUDIT MicroControls
Linearity LQ Special Diabetes


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get complete access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: The AI predictive model identifies the most potent cancer killing immune cells for use in immunotherapies (Photo courtesy of Shutterstock)

AI Predicts Tumor-Killing Cells with High Accuracy

Cellular immunotherapy involves extracting immune cells from a patient's tumor, potentially enhancing their cancer-fighting capabilities through engineering, and then expanding and reintroducing them into the body.... Read more

Microbiology

view channel
Image: The T-SPOT.TB test is now paired with the Auto-Pure 2400 liquid handling platform for accurate TB testing (Photo courtesy of Shutterstock)

Integrated Solution Ushers New Era of Automated Tuberculosis Testing

Tuberculosis (TB) is responsible for 1.3 million deaths every year, positioning it as one of the top killers globally due to a single infectious agent. In 2022, around 10.6 million people were diagnosed... Read more